Latest news for  (OTC:SSBBF) Stock

At her first big rally as the Democratic front-runner, Vice President Kamala Harris threw down the gauntlet: she vowed to "take on corporate landlords and cap unfair rent increases." In front of 10,000 supporters in Atlanta, Harris pushed a bold idea: limit rent hikes to 5% for two years for landlords with over 50 units.&nbsp;
Don't Miss:
<ul>
<li>Miami is expected to take New York's place as the U.S. Financial Capital.<a href="https://www.benzinga.com/money/miami-take-new-yorks-place-financial-capital"> Here's how you can invest in the city before that happens</a>.</li>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
</ul>
This proposal is closely aligned with a plan recently put forth by the Biden administration. That plan aims to curb rising rents while more housing is under construction. The Biden plan, however, would exempt newly built units to avoid discouraging development. Harris did not address this nuance in her speech. The proposal targets corporate landlords and is seen as a way to provide immediate relief to millions of renters, particularly in markets where <a href="https://www.benzinga.com/real-estate/24/08/40253905/governor-tim-walz-housing-is-central-to-workforce-growth-a-look-where-he-stands-on-the-market">housing affordability</a> is increasingly dire.
See Also: Will the surge continue or decline on real estate prices?<a href="https://www.benzinga.com/money/realbricks"> People are finding out about risk-free real estate investing that lets you cash out whenever you want.</a>
Her message is hitting home with voters squeezed by rising housing costs. A May poll from Navigator, a Democratic-aligned group, showed broad support for curbing rent gouging by corporate landlords. These voters are crucial to the Democratic base. But while it's scoring points on the campaign trail, economists are sounding the alarm about the plan.
<a href="https://www.benzinga.com/personal-finance/24/08/40101676/nearly-50-economists-were-asked-how-they-feel-about-president-bidens-5-rent-cap-this-is-what-the">Most economists say</a> rent control, like Harris's plan, often does more harm than good. A review of over 200 studies on rent control revealed many negative consequences: lower housing quality, less availability, and a slowdown in new construction. Rent caps can shrink the housing supply and make conditions worse in existing rentals.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Even some Democrats, like Colorado Gov. Jared Polis, warn that Harris's approach could backfire, deepening the housing crisis it aims to fix. They argue that the real solution is to build more affordable housing, not just cap rents.
"Rent control has been about as disgraced as any economic policy in the tool kit," Jason Furman, the Obama administration's top economic adviser, said recently to the Washington Post. "The idea we'd be reviving and expanding it will ultimately make our housing supply problems worse, not better."
Harris is banking on the political power of rent control to overshadow these concerns. With more than 22 million American households spending over a third of their income on rent and <a href="https://www.benzinga.com/real-estate/24/08/40187731/new-redfin-survey-reveals-more-than-a-quarter-of-homebuyers-prioritize-space-and-lower-cost-of-livin">mortgage rates rising</a> recently, the housing crisis is intensifying. Harris may face increasing pressure as her campaign progresses to reconcile voter demands with the economic pitfalls critics highlight. Whether this gamble pays off at the polls or triggers long-term problems for the housing market is still up in the air.
Read Next:
<ul>
<li>Elon Musk and Jeff Bezos are bullish on one city that could dethrone New York and become the new financial capital of the US.<a href="https://www.benzinga.com/money/miami-take-new-yorks-place-financial-capital"> Investing in its booming real estate market has never been more accessible.</a></li>
<li>A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a></li>
</ul>

News

Kamala Harris' Promise To 'Take On Corporate Landlords And Cap Unfair Rent Increases' Is A Hit With Voters But A Miss With Economists

Jaguar Health Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares are trading lower by 10% to $1.08 during Tuesday&#8217;s session after the company reported worse-than-expected <a href="https://www.benzinga.com/pressreleases/24/08/ac40335398/jaguar-health-reports-second-quarter-2024-financial-results">second-quarter results</a>.
<h2 class="wp-block-heading">What Happened?</h2>
Jaguar Health posted a loss of $4.04 per share, which came in worse than the analyst consensus estimate of a loss of $1.11 per share. ]
The company reported quarterly sales of $2.72 million, falling short of the analyst consensus estimate of $3.94 million by 31%. However, this figure reflects a slight increase of 1.6% from the $2.68 million in sales reported in the same quarter of the previous year.
The company's Mytesi prescription volume rose by 5.2% from first-quarter 2024, though it saw a slight year-over-year decline. Financially, Jaguar reduced its net loss by $2.6 million to $9.5 million compared to second-quarter 2023.
Operating losses decreased by $0.9 million, and R&amp;D expenses fell by $0.6 million due to the winding down of its OnTarget clinical trial. The company meanwhile plans a commercial launch of its FDA-approved Gelclair in October 2024 and continues to develop treatments for rare diseases.
Read Also: <a href="https://www.benzinga.com/markets/equities/24/08/40338228/starbucks-appoints-chipotle-mexican-grill-veteran-as-new-ceo-stock-soars">Starbucks Appoints Chipotle Mexican Grill Veteran As New CEO, Stock Soars</a>
<h2 class="wp-block-heading">Should I Sell My JAGX Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Jaguar Health stock currently has an RSI of 60.97, indicating neutral conditions.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
JAGX has a 52-week high of $35.34 and a 52-week low of $1.03.

JAGX

Why Jaguar Health (JAGX) Stock Is Down 15%

Trading Ideas

Watching Boeing; Shares Move Higher Amid CNBC Segment, Company Reports Backlog Of 5,506 Aircrafts

Benchmark analyst Matthew Harrigan reiterates iLearningEngines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) with a Buy and maintains $18 price target.

Price Target

Reiteration

Analyst Ratings

AILE

Benchmark Reiterates Buy on iLearningEngines, Maintains $18 Price Target

By Nicolas Jose Rodriguez and Rolando Garcia.&nbsp;
In the early 2000s, the people in Argentina&#39;s Chilecito Valley&nbsp;became a symbol of environmental resistance with their rally&nbsp;cry&nbsp;of &quot;Agua s&iacute;, oro no&quot; (Water yes, gold no). The area&#39;s&nbsp;residents vehemently&nbsp;opposed a large-scale mining project that sought to use millions of cubic meters of glacier water. The mining company&nbsp;finally abandoned its&nbsp;plans&nbsp;in 2007.
Then in 2018, the people in the <a href="https://www.tripadvisor.com/Tourism-g815503-Chilecito_Province_of_La_Rioja_Cuyo-Vacations.html">Chilecito Valley</a>&nbsp;turned their focus towards sustainable cannabis cultivation, embracing an environmentally friendly economic alternative to mega-mining.
<h3>The Best Wine...And The Best Cannabis</h3>
In an exclusive interview with Benzinga Cannabis, Benjamin Enrici, CEO of <a href="https://www.instagram.com/agrogeneticariojana/">Agrogenetica Riojana</a>&nbsp;talked about&nbsp;how cannabis is transforming the Valley. Founded in 2009, this mixed-capital company is part of a network of local greenhouses that provide plants and training to local farms.
&ldquo;We are in La Rioja, a small province, with a dry climate and lots of sunshine which is excellent for growing and processing pharma-grade cannabis. We see medical cannabis as an alternative for local producers, to command higher prices for their goods,&rdquo; says Enrici as we walked through the numerous greenhouses filled with experimental cannabis genetics from around the world.
<img alt="benjamin_enrici_ceo_agrogenetica_riojana.jpg" src="https://www.benzinga.com/files/u503488/benjamin_enrici_ceo_agrogenetica_riojana.jpg" style="height:423px; width:633px" />
Benjamin Enrici - Photo Courtesy of Agrogenetica Riojana.&nbsp;
&ldquo;We already make some of the best wines in the world, why not cannabis?&rdquo; said the agronomist referring to Argntina&#39;s&nbsp;world-renowned wines like Torrontes, Malbec, Tempranillo&nbsp;and Cabernet Franc, among others.
<h3>Made In The Chilecito Valley</h3>
Rather than centralizing production, the company connects a network of small and medium enterprises&nbsp;in the Valley&nbsp;with cannabis companies and investors, looking to conduct genetic experiments in controlled conditions.
Growing, processing&nbsp;and testing cannabis in controlled environments is hard, but being in the desert makes it a bit easier. Between the&nbsp;average temperature, humidity&nbsp;and absence of rainfall give mold, yeast, bacteria&nbsp;and plagues a hard time. Add&nbsp;those conditions&nbsp;to the skillset of local agronomists, farmers&nbsp;and <a href="https://www.benzinga.com/markets/cannabis/24/05/38930615/sustainable-cannabis-in-coachella-valley-green-horizons-1m-sq-ft-facility-tommy-hilfiger-cpg-exp">organic cultivation methods</a>,&nbsp;the result is a giant cannabis lab.
Condors, parrots, finches&nbsp;and earthcreepers swirl around the greenhouses and lab where plants are reproduced in-vitro, dried&nbsp;and tested. The background sets the scene of a cowboy movie&nbsp;or a cactus convention as plants line&nbsp;up with shrubs, up and down the hills surrounding the Famatina glacier.
<h3>Chilecito&rsquo;s Problem</h3>
The Chilecito Valley is undergoing a process of extensive mechanization of olive and nut production, which requires less labor resulting in less jobs.
In addition, and counterintuitively, mechanization is making&nbsp;operations more expensive for small and medium farmers&nbsp;who end up renting their small&nbsp;plots of land to global food corporations, with operations that can span up to&nbsp;13,000 acres.
Although commodity output is higher now than ever, profits are not necessarily shared by local producers.
&ldquo;The problem is not automation, the problem is the lack of access to credit, and the low market value of some of the commodities we produce here. If our farmers can produce a high-quality specialty crop, in smaller plots of land, then they may have a chance to thrive here,&rdquo; Enrici explained.
<h3>An Agronomist Goes&nbsp;To California And Discovers Gold</h3>
In 2012 Enrici traveled to Davis, California, looking for pistachio seeds for&nbsp;Chilecito farmers. While there, he&nbsp;learned about&nbsp;the cannabis industry. The idea of bringing this crop to Argentina began to percolate.
It was not until 2021 that Agrogen&eacute;tica Riojana was able to<a href="https://www.benzinga.com/markets/cannabis/24/06/39436658/cultivator-chronicles-genetic-advancements-in-cannabis-cultivation"> register a cannabis genetic variety </a>with the National Seed Institute, responsible for promoting the production and commercialization of seeds, ensuring their identity, and protecting the intellectual property.&nbsp;In 2024, the company became GMP and GFP certified, ensuring&nbsp;that high standards and&nbsp;farming practices are sustainable&nbsp;and socially responsible.
<h3>Growing Medicine In The Andes</h3>
To Chilecito workers and residents, cannabis was&nbsp;like a new thing.&nbsp;
Everyone knew about olive and nut&nbsp;cultivation, but&nbsp;cannabis was a different ball of wax.
Once viewed as the devil&#39;s lettuce,&nbsp;taboos fell by the wayside and the new crop&nbsp;pulled in&nbsp;the&nbsp;younger generation.&nbsp;
For 22-year-old Belen, whose college friends moved&nbsp;to Buenos Aires, cannabis became an opportunity to work in something different, where &ldquo;protocols are required, there is always something to learn.&rdquo;
As Belen puts it: &ldquo;I am in charge of cloning plants, I learned a lot working with the company. Many of my college friends work either in government or have left town to bigger cities to work and study.&rdquo;
For Roxana and Analia, who work with cannabis plants in their vegetative cycle, the industry became an alternative to providing care for others, working in the olive fields&nbsp;or cleaning houses for a living.
<h3>Chill, It&#39;s Just&nbsp;Medicinal Marijuana</h3>
Cannabis&nbsp;raised a few eyebrows at first. However,&nbsp;news of&nbsp;the benefits spread&nbsp;quickly&nbsp;and people&rsquo;s acceptance was in crescendo.
Santos, who works as a trimmer put&nbsp;it simply.&nbsp;&ldquo;I am a fourth generation&nbsp;agricultural worker&nbsp;in the Valley.&nbsp;I&#39;ve done this job for almost 30 years now. There&#39;s&nbsp;a lot I&#39;ve&nbsp;learned over the&nbsp;years that applies to cannabis...and what we don&#39;t&nbsp;know, we learn&nbsp;from the company&rsquo;s agronomist.&rdquo;&nbsp;
He added that attitudes&nbsp;soften when people&nbsp;realize&nbsp;it&#39;s medical. &ldquo;People sometimes raise their eyebrows when they hear the word cannabis, but everybody in town knows this is medicinal.&rdquo;&nbsp;
Read Also:&nbsp;<a href="https://www.benzinga.com/general/biotech/23/01/30569073/exclusive-a-600-acres-cannabis-giant-hidden-in-the-jungle-is-on-its-way-to-becoming-eu-gmp-certif">EXCLUSIVE: A 600-Acres Cannabis Giant &#39;Hidden&#39; In The Jungle Is On Its Way To Becoming EU GMP Certified, Meet Cannava</a>
<h3>A Revolutionary Plan</h3>
What&#39;s happening&nbsp;in Chilecito is cannabis innovation, but it can be viewed as a plot or a plan&nbsp;to subvert history and change the equation for the town&#39;s people.
How you ask?&nbsp;Enrici explains.&nbsp;
&ldquo;What we do is work with companies who are willing to invest in research and development of cannabis genetics for medicinal purposes. We provide advice, technology&nbsp;and some infrastructure, while private capital builds out the cultivation site and associated services,&rdquo; he told Benzinga.
&ldquo;We collaborate in the design of experiments and pheno-hunting programs with private companies. We allow global companies to conduct research at a fraction of the cost of doing the same work in Europe, Canada, or anywhere else in the world. Companies pay a fee to operate in the area and have full disposition of their production.&rdquo;&nbsp;
Why Argentina?
&ldquo;Most of the companies here are on their way to register their cannabis genetics. Why? Because Argentina is one of two, if not the only country in the world, where you can patent a legal cannabis variety, at a fraction of the cost,&rdquo; Enrici said.
<h3>A Regional Supply Chain</h3>
Sipping mate from a straw, Enrici sits in his office looking at a map of Brazil. He&nbsp;sees the neighboring market as an&nbsp;opportunity for local cannabis producers to sell their goods at a higher price.
Agrogenetica has already launched a brand of pharmaceutical cannabis oil named &ldquo;<a href="https://www.infobae.com/economia/2023/09/07/federal-lanzaron-primer-aceite-de-cannabis-medicinal-integramente-producido-en-la-rioja/">Federal</a>,&rdquo; which is sold by prescription.
Now their goal is to bring high-quality&nbsp;and efficient cost structures across the border between the two countries.
With a population of 215 million, Brazil has the largest cannabis market in South America. The government has <a href="https://www.benzinga.com/markets/cannabis/24/06/39435078/brazil-on-the-brink-of-marijuana-decriminalization-supreme-court-to-decide-next-week">started to ease regulations </a>of hemp-derived products that contain CBD.
<h3>Crunching Numbers, Looking Inward</h3>
Beyond global markets, Enrici foresees a bright green future for local farmers if Argentina regulates the market of CBD flowers for patients enrolled in the Health Ministry&#39;s medical marijuana program.
&ldquo;We can produce a high-quality flower, tons of it, without <a href="https://www.benzinga.com/markets/cannabis/24/07/39992555/cannabis-sustainability-why-it-matters-and-how-to-achieve-it-with-practical-inexpensive-measures">impacting the environment </a>and we can place it on the shelves&nbsp;of patients throughout the country,&quot; Enrici said. &quot;We have the scale, quality, and consistency to outprice non-regulated products and protect public health.&rdquo;&nbsp;
And indeed, he seems to be right. Once these two Benzinga journalists wrapped up their interview and crunched the numbers, we found that a pound of cannabis flower can be produced 26 times cheaper in Chilecito Valley than by illegal grow operations in Argentina.
Read Next:&nbsp;<a href="https://www.benzinga.com/general/biotech/23/03/31192138/exclusive-this-puerto-rican-cannabis-company-breaks-the-mold-and-is-ready-to-take-on-the-world">EXCLUSIVE: This Puerto Rican Cannabis Company Breaks The Mold And Is Ready To Take On The World</a>
These issues will be among the hot topics at the upcoming Benzinga Cannabis Capital Conference in Chicago this Oct. 8-9. Join us to get more insight into what the wave of weed legalization means for the future of investing in the industry. Hear directly from top executives, investors, advocates, and policymakers. Get your tickets now before prices go up by following this link.
Cover photo: Roxana - Rolando Garcia - 2024.&nbsp;

Biotech

Cannabis

Latin America

Emerging Markets

Entrepreneurship

Health Care

Legal

Global

Success Stories

Exclusives

Markets

Tech

Interview

General

Chilecito: A Valley In The Andes That Defeated Mega-Mining And Embraced Sustainable Cannabis

Scotiabank analyst Robert Hope maintains Algonquin Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AQN#NYSE">AQN</a>) with a Sector Perform and lowers the price target from $6.5 to $5.75.

Scotiabank Maintains Sector Perform on Algonquin Power, Lowers Price Target to $5.75

WIIM

Jaguar Health shares are trading lower after the company reported worse-than-expected second-quarter results.

Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) could face challenges in the Chinese market as Huawei Technologies prepares to launch its new AI chip, the Ascend 910C.
This chip aims to fill the void left by Nvidia after <a target="_blank" href="https://www.benzinga.com/government/24/07/39616102/despite-restrictions-nvidia-chips-are-still-reaching-china-wsj" rel="noreferrer noopener">U.S. export controls</a>, implemented in 2022, prevented the company from offering its most advanced chips, like the H100, to Chinese customers.
The impact of Huawei&#8217;s move could be substantial, as the Chinese tech giant has already garnered interest from major players like ByteDance, Baidu Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), potentially threatening Nvidia&#8217;s dominance in the region, the Wall Street Journal <a target="_blank" href="https://www.wsj.com/tech/ai/huawei-readies-new-chip-to-challenge-nvidia-surmounting-u-s-sanctions-e108187a?st=en0vpjcasing7jv&amp;mod=googlenewsfeed" rel="noreferrer noopener">reports</a>.
If Huawei successfully produces the Ascend 910C and Nvidia remains restricted from selling its top-tier chips to China, Nvidia could see a rapid decline in its market share.
Industry analysts suggest that Huawei&#8217;s new chip may outperform Nvidia&#8217;s downgraded B20, which was designed to comply with U.S. export regulations. With orders for the 910C expected to reach over 70,000 units, valued at approximately $2 billion, Huawei is positioning itself as a formidable competitor.
Nvidia has maintained that the U.S. embargo on China has had no impact. The stock is up over 149% in the last 12 months, <a target="_blank" href="https://www.benzinga.com/news/24/08/40319192/whats-going-on-with-nvidia-stock-on-monday" rel="noreferrer noopener">backed by its</a> &#8220;walled garden&#8221; of developers who use its chips to build AI systems and other software. As Nvidia focuses on its coding expertise, it will likely maintain more leverage than its rivals.
Investors can gain exposure to Nvidia through SPDR Select Sector Fund &#8211; Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) and Vanguard Information Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGT#NYSE">VGT</a>).
Price Action: NVDA shares traded higher by 5.05% at $114.53 at the last check on Tuesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Nvidia Blog

Government

Regulations

Movers

Media

BIDU

NVDA

What's Going On With Nvidia Stock On Tuesday?

Benchmark analyst Mark Palmer reiterates Repay Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) with a Buy and maintains $13 price target.

RPAY

Benchmark Reiterates Buy on Repay Holdings, Maintains $13 Price Target

To gain an edge, this is what you need to know today.
<figure class="wp-block-image size-large is-resized"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2024/08/2024-08-13_08h35_31.png" alt="" style="width:624px" /></figure>
<h3 class="wp-block-heading">Misleading Headline</h3>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-consumer-weakness-cooler-producer-price-index-hd-mc-08132024">click here</a> for an enlarged chart of Home Depot Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>).
Note the following:
<ul>
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of HD stock is being used to illustrate the point.</li>
<li>Home Depot is an important stock because it is the largest home improvement retailer and its earnings give a glimpse into consumer sentiment.&nbsp; HD is also a component of the Dow Jones Industrial Average (DJIA).</li>
<li>The chart shows that HD pulled back 20% from its high in March to its low in May.</li>
<li>The chart shows that the rally from the low has made a double top.&nbsp; A double top is a negative pattern.</li>
<li>The chart shows that the double top was made at a level significantly below the high.&nbsp; This is a negative.</li>
<li>The chart shows the price drop on earnings.</li>
<li>HD reported good earnings but the stock is falling on weaker comp sales outlook.&nbsp; The weaker comp sales outlook shows that the consumer is weakening.&nbsp; Here are the details:
<ul>
<li>HD sees FY24 comp sales down 3% &#8211; 4% vs. down 1% prior.</li>
<li>HD reports adjusted EPS of $4.67 vs. $4.49 consensus.</li>
<li>HD reports revenues of $43.18B vs. $43.06B consensus.</li>
</ul>
</li>
<li>RSI on the chart shows that HD stock is now oversold.</li>
<li>On the surface, Producer Price Index (PPI) came weaker than expected.&nbsp; Here are the details:
<ul>
<li>Headline PPI came at 0.1% vs. 0.1% consensus.</li>
<li>Core PPI came at 0.0% vs. 0.2% consensus.</li>
</ul>
</li>
<li>As of this writing, the stock market is running up focusing on PPI headline.&nbsp; However, in The Arora Report analysis, digging below the surface, the data is not as good as it seems.&nbsp; PPI ex-food, energy, and trade came at 0.3% vs. 0.2% consensus.&nbsp; This indicates the companies' profit margins are compressing and in actuality, inflation is higher than reflected in the headline.&nbsp;&nbsp;</li>
<li>In The Arora Report analysis, compression in margins has a negative read through for earnings.&nbsp; This data, along with several other pieces of data, is indicating that Wall Street's estimates for future earnings may be too high.&nbsp;&nbsp;</li>
<li>Prudent investors know that in the long run, earnings are the single best determinant of the stock market.</li>
<li>Consumer Price Index (CPI) will be released tomorrow at 8:30am ET.&nbsp; CPI is more important than PPI.</li>
</ul>
<h3 class="wp-block-heading">Magnificent Seven Money Flows</h3>
In the early trade, money flows are positive in Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Alphabet Inc Class C (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
In the early trade, money flows are mixed in SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
<h3 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h3>
Investors can gain an edge by knowing money flows in SPY and QQQ.&nbsp; Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.&nbsp; The most popular ETF for gold is SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>).&nbsp; The most popular ETF for silver is iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>).&nbsp; The most popular ETF for oil is United States Oil ETF (ASCA:USO).
<h3 class="wp-block-heading">Bitcoin</h3>
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is range bound.
<h3 class="wp-block-heading">Protection Band And What To Do Now</h3>
It is important for investors to look ahead and not in the rearview mirror.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h3 class="wp-block-heading">Traditional 60/40 Portfolio</h3>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

$BTC

AAPL

AMZN

GOOG

MSFT

TSLA

Pay Attention: Inflation Headline Is Misleading, Home Depot Earnings Show Consumer Weakness

Piper Sandler analyst Brian Mullan upgrades Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) from Neutral to Overweight and raises the price target from $85 to $103.

Upgrades

SBUX

Piper Sandler Upgrades Starbucks to Overweight, Raises Price Target to $103

ILMN

Illumina shares are trading lower amid the company's outlook at its investor presentation.

Wells Fargo analyst Praneeth Satish maintains Ballard Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDP#NASDAQ">BLDP</a>) with a Underweight and lowers the price target from $3 to $2.

BLDP

Wells Fargo Maintains Underweight on Ballard Power Systems, Lowers Price Target to $2

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) traders remain defiant in light of prolonged sideways price action and still see $0.20 as a <a href="https://www.benzinga.com/money/dogecoin-doge-price-prediction">viable price target</a>.
What Happened: Crypto trader Astronomer <a href="https://x.com/astronomer_zero/status/1823165355495469402">thinks</a> Dogecoin has remained strong despite the broader market downturn. Unlike many projects that have dipped below their prices at the end of 2023, DOGE has held its structure, showcasing relative strength.
The trader has high conviction in DOGE due to its strong community support, backing from big names and a technically solid chart. The recent price action aligns with expectations, with DOGE respecting its cyclical patterns.
The next key move is a break above the local high, which could signal a run to higher targets. The trader said he is watching closely, as Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) pullback could influence DOGE&#8217;s next move. 
Another crypto trader sees Dogecoin's breakout target at $0.20 after its bounce from horizontal support.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> Falling Channel ! This formation is a Bullish biased pattern and it is most likely to break to the topside.<a href="https://twitter.com/hashtag/DOGE?src=hash&amp;ref_src=twsrc%5Etfw">#DOGE</a> also bounced from horizontal support. The Break Out target for <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> will be $0.20 <a href="https://t.co/Odl7IwkSFw">pic.twitter.com/Odl7IwkSFw</a>
&mdash; Crypto Yapper (@CryptoYapper) <a href="https://twitter.com/CryptoYapper/status/1823316316985462850?ref_src=twsrc%5Etfw">August 13, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40320994/whats-going-on-with-dogecoin-and-shiba-inu-this-week">What&#8217;s Going On With Dogecoin And Shiba Inu This Week?</a>
Why It Matters: IntoTheBlock data shows large transaction volume down by 30.2%, while daily active addresses saw a decline of 4.3%. Exchanges netflows declined by 100%. Currently, 73% of Dogecoin holders are in profit.
Over the past year, Dogecoin saw a 37.4% increase in prices. It is up 9% over the past week and holding on to the psychological mark of $0.1.  
Crypto trader Jackis noted that Dogecoin's chart is clean and <a href="https://x.com/i_am_jackis/status/1823279228642566435">stated</a> it is the "best risk-return probability setup you'll get for it this cycle."
What&#8217;s Next: The influence of meme coins and <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a> is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40287367/dogecoins-whale-transactions-surge-but-does-it-really-have-10x-potential">Dogecoin&#8217;s Whale Transactions Surge But Does It Really Have &#8217;10x Potential&#8217;?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

Dogecoin 'Still On Its Path,' Trader Predicts $0.20 As Breakout Target

On Tuesday, Baxter International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAX#NYSE">BAX</a>) agreed to sell its Kidney Care segment, Vantive, <a href="https://www.benzinga.com/markets/equities/24/07/39663935/carlyle-eyes-4b-acquisition-of-baxters-kidney-care-unit-vantive-report" target="_blank" rel="noreferrer noopener">for $3.8 billion</a> to The Carlyle Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>)
Baxter will receive approximately $3.5 billion in cash, with net after-tax proceeds currently estimated <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40333262/baxter-announces-definitive-agreement-to-divest-its-vantive-kidney-care-segment-to-carlyle-for-3-8" rel="noreferrer noopener">at approximately $3 billion</a>.
Baxter announced its intention to create a standalone kidney care company in January 2023 as part of its broader strategic realignment designed to enhance future performance and create value for all stakeholders.
In March 2024, Baxter announced that it was in discussions to explore a <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/07/39941094/carlyles-4b-purchase-of-baxters-kidney-division-backed-by-ares-and-hps-financing" rel="noreferrer noopener">potential sale of the segment</a>.
Vantive offers products and services for peritoneal dialysis, hemodialysis, and organ support therapies, including continuous renal replacement therapy.
The business has more than 23,000 employees globally and had 2023 revenues of $4.5 billion.
The transaction is expected to close in late 2024 or early 2025.
Following the completion of the pending sale of Kidney Care, Baxter is targeting operational sales <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40191263/baxter-lifts-annual-outlook-after-strong-q2-beat-medical-devices-sales" rel="noreferrer noopener">growth of 4% to 5% annually</a>.
For 2025, the company anticipates an adjusted operating margin&nbsp;of approximately 16.5% on a continuing operations basis, which reflects an anticipated 100-basis-point negative impact due to stranded costs and the manufacturing supply agreement Baxter will enter into upon the completion of the divestiture of the Kidney Care segment.
Baxter will continue prioritizing capital allocation and expects to direct investments toward higher-growth, higher-return opportunities to drive incremental value.
To support these efforts, Baxter will focus on deleveraging and expects to achieve its investment-grade target of a debt-to-equity ratio below 3.0x by the end of 2025. This goal will be supported by using proceeds from the sale of its Kidney Care segment to repay outstanding debt, including its new bridge facility.
Price Action: BAX stock is down 6.9% at $34.37 at last check Tuesday. The stock initially gained following the announcement but has since reversed.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/08/40339633/marriott-pursues-damages-from-franchisee-for-unauthorized-hotel-use-as-migrant-shelter" target="_blank" rel="noreferrer noopener">Marriott Pursues Damages From Franchisee For Unauthorized Hotel Use As Migrant Shelter</a></li>
</ul>
Photo: Shutterstock

Large Cap

Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment

Rumble Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUM#NASDAQ">RUM</a>) shares are volatile Tuesday after the company reported better-than-expected results <a href="https://www.benzinga.com/news/earnings/24/08/40324773/rumble-q2-earnings-highlights-revenue-beat-eps-beat-3-million-more-monthly-users-as-2024-election-d">for the second quarter</a>.
What Happened: Rumble reported second-quarter revenue of $22.469 million, beating <a href="https://www.benzinga.com/calendars/earnings">analyst estimates</a> of $19.69 million. The company reported a quarterly loss of 13 cents per share, beating estimates for a loss of 15 cents per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Total revenue was down from $25 million on a year-over-year basis, but up 27% sequentially. Average monthly active users came in at 53 million, up from 50 million in the first quarter. Average revenue per user was 37 cents. Rumble noted that the second quarter was its tenth straight quarter with more than 40 million average global monthly active users.
Rumble said it hit new company records for concurrent livestream viewers during the first presidential debate between President&nbsp;Joe Biden&nbsp;and former President&nbsp;Donald Trump in June. The company noted that it hit a peak of 718,909 concurrent live viewers.
Related Link: <a href="https://www.benzinga.com/news/earnings/24/08/40324773/rumble-q2-earnings-highlights-revenue-beat-eps-beat-3-million-more-monthly-users-as-2024-election-d">Rumble Q2 Earnings Highlights: Revenue Beat, EPS Beat, 3 Million More Monthly Users As 2024 Election Drives Audience To Platform</a>
&#8220;The&nbsp;second quarter&nbsp;evidenced proof and traction that our audience is ripe for monetization,&#8221; said Chris Pavlovski, chairman and CEO of Rumble.
&#8220;With our focus on monetization and our product suite fully online, we are pleased with the early adoption that has taken hold, as is evident in both the progression of Cloud customers onboarded as well as the evolution of conversations to drive further partnerships expanding our total addressable market within the cloud space.&#8221;
Rumble ended the quarter with $154.2 million in cash, cash equivalents and marketable securities.
Following the print, Wedbush analyst Scott Devitt reiterated Rumble with a <a href="https://www.benzinga.com/analyst-stock-ratings">Neutral rating</a> and maintained a price target of $8.
RUM Price Action: <a href="http://benzinga.com/quote/RUM" target="_blank" rel="noreferrer noopener">Rumble shares</a> traded up above the $6.30 level on the report before pulling back. The stock was up 3.65% at $5.96 at the time of publication, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Shutterstock.

Earnings

What's Going On With Rumble Stock Tuesday?

Guidance

Illumina Says Co & Broad Institute Of MIT And Harvard Announce Research Partnership To Advance Single-Cell Sequencing; Expects Its Strategy To Enable Company To Accelerate Its Revenue Growth To High Single Digits By 2027

Boeing Delivered 218 Airplanes Year-To-Date Through July, Including 166 MAX; Reports 43 Commercial Jet Deliveries In July, Matching Last Year's Numbers, With 31 737 MAX; 228 Gross Aircraft Orders Through July, 72 In July Alone Including 57 For 737 MAX; Net 186 Orders After Cancellations/Conversions; Six 787 Jets Delivered In July; One 737 MAX Cancellation From Aerolineas Argentinas

Over the past 24 hours, Maker's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/mkr/usd">MKR</a>) price rose 5.28% to $2,105.07. This continues its positive trend over the past week where it has experienced a 10.0% gain, moving from $1,937.23 to its current price. As it stands right now, the coin's all-time high is $6,292.31. 
The chart below compares the price movement and volatility for Maker over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1723561423_0.png" alt="price_chart" />
The trading volume for the coin has decreased 39.0% over the past week, while the overall circulating supply of the coin has increased 0.01% to over 930 thousand. This puts its current circulating supply at an estimated 92.52% of its max supply, which is 1.01 million. The current market cap ranking for MKR is #42 at $1.95 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1723561423_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$MKR

Cryptocurrency Maker Rises More Than 5% In 24 hours

ULICE PAYNE JR, Director at WEC Energy Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEC#NYSE">WEC</a>), executed a substantial insider sell on August 12, according to an SEC filing.
What Happened: JR's recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000783325/000010781524000214//Archives/edgar/data/783325/000010781524000214/0000107815-24-000214-index.htm">U.S. Securities and Exchange Commission</a> on Monday unveiled the sale of 750 shares of WEC Energy Group. The total transaction value is $66,340.
Tracking the Tuesday's morning session, WEC Energy Group shares are trading at $89.26, showing a up of 0.02%.
<h3>About WEC Energy Group</h3>
WEC Energy Group's electric and gas utility businesses serve electric and gas customers in Illinois, Michigan, Minnesota, and Wisconsin service territories. The company also owns a 60% stake in American Transmission Co. WEC's asset mix is approximately 48% electric generation and distribution, 36% gas distribution, 10% electric transmission, and 6% unregulated renewable energy.
<h3>WEC Energy Group: Delving into Financials</h3>
Decline in Revenue: Over the 3 months period, WEC Energy Group faced challenges, resulting in a decline of approximately -3.17% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Utilities sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 43.39%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): WEC Energy Group's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 0.67.
</li>
</ul>
Debt Management: WEC Energy Group's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.56, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: A higher-than-average P/E ratio of 20.61 suggests caution, as the stock may be overvalued in the eyes of investors.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 3.27 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 12.79, WEC Energy Group demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Transaction Codes Worth Your Attention</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000783325">Check Out The Full List Of WEC Energy Group's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

WEC Energy Group Director Sold $66K In Company Stock

SSgA SPDR ETFs Europe I PLC SPDR BBG US TIPS UCITS ETF

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

News

Latest news for (OTC:SSBBF) Stock